We only observed higher expression of three genes (HMGB2, CCNA2 and CASP3) in the glioma tissues (Figures 15G–I), consistent with the conclusions from the previous analysis based on the TCGA cohort. The gene discussed is HMGB2; the disease is central nervous system cancer.